Medtronic plc
MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitorinā¦ read more
Healthcare
Medical Devices
52 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$87.38
Price-1.79%
-$1.59
1Y
Price
Market Cap
$112.186b
Large
Price/Earnings 3y Avg5y Avg
24.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+27.6%
EBITDA Margin+12.7%
Net Profit Margin+25.5%
Free Cash Flow Margin+27.6%
EBITDA Margin+12.7%
Net Profit Margin+25.5%
Free Cash Flow MarginRevenue
$35.484b
+5.8%
1y CAGR+4.4%
3y CAGR+2.9%
5y CAGREarnings
$4.614b
-1.0%
1y CAGR+7.9%
3y CAGR-0.5%
5y CAGREPS
$3.59
-0.5%
1y CAGR+9.4%
3y CAGR+0.9%
5y CAGRBook Value
$49.196b
$91.485b
Assets$42.289b
Liabilities$28.071b
DebtDebt to Assets
30.7%
3x
Debt to EBITDAFree Cash Flow
$5.410b
+4.3%
1y CAGR+5.9%
3y CAGR-1.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company